Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 864,930
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 449,967
Total Sell Value $0 $0 $8,245,949 $81,866,696
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 69
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1805
  Page 55 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baker Felix Director   –       •       •   2009-08-11 4 B $10.75 $2,939,093 I/I 273,404 4,626,213 2.25     -
   Baker Felix Director   –       •       •   2009-08-11 4 B $10.75 $463,691 I/I 43,134 214,613 2.25     -
   Baker Felix Director   –       •       •   2009-08-11 4 B $10.75 $8,579 I/I 798 481,890 2.17     -
   Baker Felix Director   –       •       •   2009-08-11 4 B $10.75 $16,798,638 I/I 1,562,664 10,246,673 2.25     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2009-07-30 4 S $12.47 $311,725 D/D (25,000) 3,713     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2009-07-30 4 OE $8.24 $206,000 D/D 25,000 28,713     -
   Dobmeier Eric Chief Business Officer   •       –      –    2009-07-30 4 S $12.36 $417,050 D/D (33,734) 12,206     -
   Dobmeier Eric Chief Business Officer   •       –      –    2009-07-30 4 OE $4.45 $176,063 D/D 33,734 23,951     -
   Dobmeier Eric Chief Business Officer   •       –      –    2009-07-29 4 S $12.36 $324,755 D/D (26,266) 12,206     -
   Dobmeier Eric Chief Business Officer   •       –      –    2009-07-29 4 OE $4.45 $95,489 D/D 19,266 22,738     -
   Berger Franklin M Director   –       •      –    2009-07-29 4 OE $4.18 $20,900 D/D 5,000 77,220     -
   Rosenberg Morris EVP, Development   •       –      –    2009-07-28 4 S $11.81 $295,243 D/D (25,000) 0     -
   Rosenberg Morris EVP, Development   •       –      –    2009-07-28 4 OE $6.72 $168,000 D/D 25,000 25,000     -
   Gryska David W Director   –       •      –    2009-07-20 4 OE $5.00 $20,000 D/D 4,000 17,500     -
   Akkaraju Srinivas Director   –       •      –    2009-06-25 4 B $9.20 $50,633 D/D 5,500 5,500 2.39     -
   Baker Felix Director   –       •       •   2009-05-20 4 B $9.72 $3,674,675 I/I 378,053 4,352,809 2.25     -
   Baker Felix Director   –       •       •   2009-05-20 4 B $9.72 $141,679 I/I 14,576 171,479 2.25     -
   Baker Felix Director   –       •       •   2009-05-20 4 B $9.72 $7,256,670 I/I 746,571 8,684,009 2.25     -
   Baker Felix Director   –       •       •   2009-05-20 4 B $9.72 $36,061 I/I 3,710 481,092 2.25     -
   Baker Felix Director   –       •       •   2009-05-20 4 B $9.72 $342,659 I/I 35,253 400,898 2.25     -
   Dobmeier Eric Chief Business Officer   •       –      –    2008-12-15 4 OE $5.25 $26,250 D/D 5,000 19,000     -
   Dobmeier Eric Chief Business Officer   •       –      –    2008-09-29 4 OE $5.25 $26,250 D/D 5,000 14,000     -
   Dobmeier Eric Chief Business Officer   •       –      –    2008-09-26 4 S $11.53 $281,575 D/D (24,427) 9,000     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2008-09-22 4 S $12.52 $154,112 D/D (12,309) 2,626     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2008-09-22 4 OE $8.24 $101,426 D/D 12,309 14,935     -
  1805 Records found
  Previous  50  51  52  53  54  55  56  57  58  59  Next   
  Page 55 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us